United Orthopedic Corporation · TPEX:4129
United Orthopedic — 2021 Investor Conference
25 slides from United Orthopedic's conference presentation, Dec 10, 2021
Slide 1: United Orthopedic Corporation 2021 Investor Conference
United Orthopedic Corporation 2021 Investor Conference Jason Lin December 10, 2021
Slide 2: Safe Harbor Notice
Safe Harbor Notice Except for historical information set forth herein, this presentation contains certain forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from what may be expressed or implied by such statements. Investors sh
Slide 3: Agenda
Agenda Financial Results Business Update Q&A 3
Slide 4: Revenue & Net Profit
Revenue & Net Profit (NT$ thousands) (consolidated) 2,000,000 1,000,000 0 Q1~Q3 2020 Q1~Q3 2021 Revenue 1,663,664 1,840,953 +11% Operating Profit 33,413 96,514 +189% Net Profit 47,434 18,985 - 60% EPS 0.38 - 4
Slide 5: Operating Results
Operating Results Revenue Trend Chart Financial Ratios (NT$ millions) +11% 1,841 1,664 74% 12% 73% 16% 72% 72% 71% 70% 88% 69% 68% 84% 67% 67% 66% 65% 65% 63% Q1~Q3 2020 Q1~Q3 2021 Margin % OP EXP % Sales (UOC) Sales (A-Spine) Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 5
Slide 6: Cases of Artificial Joint Replacement
Cases of Artificial Joint Replacement 6
Slide 7: First Three Quarter Revenue Breakdown (2020 vs. 2021)
First Three Quarter Revenue Breakdown (2020 vs. 2021) Europe, USA and Japan resumed growing while the COVID-19 pandemic slowing down. China sales declined due to an inventory adjustment in supply chain; A-Spine sales decreased due to the COVID-19 impact. (NT$ thousands) 500,000 +4% Q1~Q3'20 Q1~Q
Slide 8: Revenue by Regions (2020 vs. 2021)
Revenue by Regions (2020 vs. 2021) Q1~Q3’20 Q1~Q3’21 JPN 2% OEM 0% JPN 3% OEM 0% A-Spine A-Spine TW 12% TW 16% 27% 26% EU EU 15% 20% INTL's INTL's 11% 13% China China USA USA 9% 14% 17% 15% 8
Slide 9: USA Market Development
USA Market Development 2021.09.01 ~ 2021.09.03 Sales Performance American Academy of Orthopaedic Surgeons (AAOS) (USD millions) 10.9 8.3 Q1~Q3 2020 Q1~Q3 2021 9
Slide 10: Europe Market Development
Europe Market Development 2021.10.08 ~ 2021.10.09 12 Sales Performance United European Academy (EUR millions) 10.8 7.4 6 0 Q1~Q3 2020 Q1~Q3 2021 10
Slide 11: Japan Market Development
Japan Market Development Sales hit record high for two consecutive seasons. Sales Performance 2021.07.07 ~ 2021.07.08 Annual Meeting of the Japanese (JPY millions) Society for Replacement Arthroplasty 220 140 Q1~Q3 2020 Q1~Q3 2021 11
Slide 12: China Market Development
China Market Development Sales Performance Chinese brand name products launch plan: (RMB millions) 8 items are launched by the end of 2021; 6 items are launched by April, 2022. 2021 2022 TYPE ITEM 130 PS/CR polyethylene insert 6 7 8 9 10 11 12 1 2 3 4 Revision products KNEE Mobile bearing tibial b
Slide 13: Spine Market Development
Spine Market Development Sales Performance A-SPINE Asia Co., Ltd. (stock ticker 6758) (NTD millions) Establish June 2001 263 spinal implants and Products instruments 228 Capital NT$ 135 million 2021 Sales NT$ 228 million (Q1~Q3) 2021 P/L NT$ 14 million (Q1~Q3) EPS NT$ 1.07 Q1~Q3 2020 Q1~Q3 2021 13
Slide 14: New Product Launch in 2021 AAOS USTAR II Limb Salvage System
New Product Launch in 2021 AAOS USTAR II Limb Salvage System 14
Slide 15: USTAR II – target on large medical centers and the hospitals
USTAR II – target on large medical centers and the hospitals that specializes in orthopedic surgery 15
Slide 16: USTARII Limb Salvage System
USTARII Limb Salvage System • Patented hinge design (US patent no. 10064732B) • Simple assembly mechanism to reduce operation time • Bone preservation design to achieve the least amount of bone removal in the market 280 cases • Launched in US and Taiwan ; will be launched in 1 year , Taiwan and USA
Slide 17: 10 Gold Award
USTAR II Limb Salvage System Winning of Taiwan Excellence Gold Award 2022 Participant Award Winning 1179 companies 10 Gold Award 20 Silver Award 355 Taiwan Excellence 17
Slide 18: 2021 Taiwan Annual Reconstruction Conference (TARC)
2021 Taiwan Annual Reconstruction Conference (TARC) Jiaoxi - Nov 26th-27th, 2021 Attending Surgeon Participant State 70 on site 6 Asia 3 Europe 130 on line 3 LATAM 1 US 18
Slide 19: Conformity Stem
2021 New Product Conformity Stem • Collaboration with the surgeon in the world-class hospital (Hospital for Special Surgery, US) • Full range 57 stems for different clinical demands • Launched in US, Europe, and Japan 19
Slide 20: Locking cage UDM Dual-mobility acetabular system
2021 New Product– HIP Locking cage UDM Dual-mobility acetabular system • Launched in Taiwan and US • Launched in Europe and Japan • Specially designed for complex acetabular revision • Popular product in Europe, which will enhance sales • 2021 National Innovation performance in Europe. Awards Renewa
Slide 21: 2021 New Product– KNEE
2021 New Product– KNEE MBA Mobile Bearing TPS Coated PS Plus Insert Tibial Baseplate Baseplate • Launched in Europe • Launched in Europe • Launched in US • To improve surgical • Biological fixation • Product line enrichment practicality 21
Slide 22: Products under Development - KNEE
Products under Development - KNEE • Target on US market • Biological fixation knee • Target on Taiwan market • Mold for infection control 22
Slide 23: Products under Development - HIP
Products under Development - HIP • Target on global markets • Modular design for revision hip surgery • Target on global markets • Modular dual-mobility acetabular system 23
Slide 24: Business Updates
Business Updates Continually implementing the rules on prudential operations under the constant concern of COVID-19. The launch of new products will mainly drive the company’s sales growth. 24
Slide 25: Thank you for listening
Thank you for listening Each Step We Care